Alen Džubur

ORCID: 0000-0003-1198-540X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiovascular Function and Risk Factors
  • Heart Failure Treatment and Management
  • Cardiac Imaging and Diagnostics
  • Blood Pressure and Hypertension Studies
  • Atrial Fibrillation Management and Outcomes
  • Acute Myocardial Infarction Research
  • Lipoproteins and Cardiovascular Health
  • Venous Thromboembolism Diagnosis and Management
  • Cardiac Health and Mental Health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Cardiovascular Health and Disease Prevention
  • Cardiovascular Disease and Adiposity
  • Dialysis and Renal Disease Management
  • Cardiac Valve Diseases and Treatments
  • Hormonal Regulation and Hypertension
  • Biomarkers in Disease Mechanisms
  • Hemodynamic Monitoring and Therapy
  • Folate and B Vitamins Research
  • Cardiac electrophysiology and arrhythmias
  • Cerebrovascular and Carotid Artery Diseases
  • Acute Ischemic Stroke Management
  • GDF15 and Related Biomarkers
  • Congenital Heart Disease Studies
  • Mechanical Circulatory Support Devices
  • Health, psychology, and well-being

University of Sarajevo
2015-2024

Clinical Center University of Sarajevo
2013-2024

University Clinical Center Tuzla
2016-2024

Sarajevo School of Science and Technology
2024

University of Bihać
2024

Institute for Rheumatic Diseases (Japan)
2019

University Clinical Centre
2018

University of Zenica
2018

Elena Arbelo Alexandros Protonotarios Juan R. Gimeno Eloisa Arbustini Roberto Barriales‐Villa and 95 more Cristina Basso Connie R. Bezzina Elena Biagini Nico A. Blom Rudolf A. de Boer Tim De Winter Perry Elliott Marcus Flather Pablo García‐Pavía Kristina H. Haugaa Jodie Ingles Ruxandra Jurcuţ Sabine Klaassen Giuseppe Limongelli Bart Loeys Jens Mogensen Iacopo Olivotto Antonios Pantazis Sanjay Sharma J. Peter van Tintelen James S. Ware Juan Pablo Kaski Philippe Charron Massimo Imazio Magdy Abdelhamid Victor Aboyans Michael Arad Folkert W. Asselbergs Riccardo Asteggiano Zofia T. Bilińska Damien Bonnet Henning Bundgaard Nuno Cardim Jelena Čelutkienė Maja Čikeš Gaetano Maria De Ferrari Veronica Dusi Volkmar Falk Laurent Fauchier Estelle Gandjbakhch Tiina Heliö Konstantinos C. Koskinas Dipak Kotecha Ulf Landmesser George Lazaros Basil S. Lewis Aleš Linhart Maja‐Lisa Løchen Benjamin Meder Richard Mindham James Moon Jens Cosedis Nielsen Steffen E. Petersen Eva Prescott Mary N. Sheppard Gianfranco Sinagra Marta Sitges Jacob Tfelt‐Hansen Rhian M. Touyz Rogier J. A. Veltrop Josef Veselka Karim Wahbi Arthur A.M. Wilde Katja Zeppenfeld B. Kichou Hamayak Sisakian Douglas S. Scherr Bernhard Gerber Alen Džubur Мариана Господинова Ivo Planinc Hera Heracleous Moustra David Zemánek Morten K. Jensen Ahmad Samir Kairit Palm Tiina Heliö Karim Wahbi Eric Schulze‐Bahr Vlachopoulos Haralambos Róbert Sepp Berglind Aðalsteinsdóttir Deirdre Ward Miry Blich Gianfranco Sinagra Afrim Poniku Olga Lunegova Ainārs Rudzītis Roland Kassab Jūratė Barysienė Steve Huijnen Tiziana Felice Eleonora Vataman Nikola Pavlović Nawal Doghmi

10.1093/eurheartj/ehad194 article EN European Heart Journal 2023-08-25
Adam Timmis Panos Vardas Nick Townsend Aleksandra Torbica Hugo A. Katus and 95 more Delphine De Smedt Chris P Gale Aldo P. Maggioni Steffen E. Petersen Radu Huculeci Dzianis Kazakiewicz Víctor de Benito Rubio Barbara Ignatiuk Zahra Raisi‐Estabragh Agnieszka Pawlak Efstratios Karagiannidis Roderick W Treskes Dan Gaiţă John F. Beltrame Alex McConnachie Isabel Bardinet Ian Graham Marcus Flather Perry Elliott Elías Mossialos Franz Weidinger Stephan Achenbach Lezha Mimoza Goda Artan Aurel Demiraj Mohammed Chettibi Naima Hammoudi Katarine Vardanyan Sergey Pepoyan Hamayak Sisakian Douglas S. Scherr Peter Siostrzonek Bernhard Metzer İsah Mustafayev Tofig Jahangirov Yasmin Rustamova N. P. Mitkovskaya Natalya Shibeka Valeriy I Stelmashok Michel De Pauw Patrizio Lancellotti Marc J. Claeys Zumreta Kušljugić Alen Džubur Elnur Smajić Mariya Tokmakova Vassil Traykov Davor Miličić Marijan Pašalić Saša Pavasović Theodoros Christodoulides Ilias Papasavvas Christos Eftychiou Aleš Linhart Miloš Táborský Martin Hutyra Jacob Thorsted Sørensen Mads Jønsson Andersen Steen Dalby Kristensen Magdy Abdelhamid Khaled Shokry Priit Kampus Mika Laine Matti Niemelä Bernard Iung Ariel Cohen Christophe Leclercq Dali Trapaidze Kakhaber Etsadashvili Alexander Aladashvili Kurt Bestehorn Stephan Baldus Andreas M. Zeiher John Kanakakis Alexandria Patrianakos Christina Chrysohoou Zoltán Csanádi Dávid Becker Zoltán Járai Þórdís Jóna Hrafnkelsdóttir Vincent Maher James L. Crowley Barbra Dalton Arik Wolak Eyal Ben‐Assa Barak Zafrir Adriano Murrone Carmen Spaccarotella Stefano Urbinati Berkinbayev Salim Sakhov Orazbek Abdrakhmanov Ayan Gani Bajraktari Docor Afrim Poniku Erkin М Мirrakhimov

Abstract Aims This report from the European Society of Cardiology (ESC) Atlas Project updates and expands upon widely cited 2019 in presenting cardiovascular disease (CVD) statistics for 57 ESC member countries. Methods results Statistics pertaining to 2019, or latest available year, are presented. Data sources include World Health Organization, Institute Metrics Evaluation, Bank, novel sponsored data on human capital infrastructure healthcare delivery. New material this includes...

10.1093/eurheartj/ehab892 article EN European Heart Journal 2021-12-20
Giulia Ferrannini Dirk De Bacquer Guy De Backer Kornelia Kotseva Linda Mellbin and 95 more David Wood Lars Rydén Chris P Gale Branko Beleslin Andrzej Budaj Ovidiu Chioncel Nikolaos Dagres Nicolas Danchin David Erlinge Jonathan Emberson Michael Glikson Alastair Gray Meral Kayıkçıoğlu Aldo P. Maggioni Klaudia Vivien Nagy Aleksandr Nedoshivin Anna-Sonia Petronio Jolien W. Roos‐Hesselink Lars Wallentin Uwe Zeymer Kornelia Kotseva Guy De Backer Ana Abreu Carlos Aguíar Jolita Badarienė Jan Bruthans Almudena Castro Conde Renata Cífková Jim Crowley Kairat Davletov Dirk De Bacquer Delphine De Smedt Johan De Sutter Jaap W. Deckers Mirza Dilić Maryna Dolzhenko H. Druais Vilnis Dzērve Andrejs Ērglis Zlatko Fras Dan Gaiţă Nina Gotcheva Diederick E. Grobbee Viveca Gyberg Hosam Hasan Ali Peter U. Heuschmann Arno W. Hoes Piotr Jankowski Nebojša Lalić Seppo Lehto Dragan Lović S. Mancas Pedro Marques‐Vidal Linda Mellbin Davor Miličić Erkin М Мirrakhimov Oganov Rg Nana Pogosova Željko Reiner Lars Rydén Martin Stagmo Stefan Störk Jouko Sundvall Lâle Tokgözoğlu Costas Tsioufis Duško Vulić David Wood Arno W. Hoes Catriona Jennings Agnieszka Adamska S. Adamska L.J. Tuomilehto Oliver Schnell Laura Råman Anne‐Marie Willems Michel De Pauw Pieter Vervaet Jessa Ziekenhuis J. Bollen E. Dekimpe N. Mommen G. Van Genechten Paul Dendale Audrey Bouvier Patrick Chenu D. Huyberechts Alexandre Persu Alden Begić Azra Durak-Nalbantić Alen Džubur N. Hadzibegic Amer Iglica S. Kapidjic A. Osmanagic Bico Nerma Resić

OBJECTIVE Dysglycemia, in this survey defined as impaired glucose tolerance (IGT) or type 2 diabetes, is common patients with coronary artery disease (CAD) and associated an unfavorable prognosis. This European investigated dysglycemia screening risk factor management of CAD relation to standards guidelines for cardiovascular subjects. RESEARCH DESIGN AND METHODS The Society Cardiology’s Observational Research Programme (ESC EORP) Action on Secondary Primary Prevention by Intervention Reduce...

10.2337/dc19-2165 article EN Diabetes Care 2020-02-20

The term masked hypertension (MH) should be used for untreated individuals who have normal office blood pressure but elevated ambulatory pressure. For treated patients, this condition termed uncontrolled (MUCH).Masked (MUCH) has gone unrecognized because few studies 24-h ABPM to determine the prevalence of suboptimal BP control in seemingly well-treated and there are such large cohorts patients attending usual clinical practice. This is important associated with a high risk cardiovascular...

10.5455/medarh.2016.70.274-279 article EN Medical Archives 2016-01-01

To assess serum levels of tumor marker carbohydrate antigen 125 (CA125) in patients with heart failure (HF) and to investigate possible correlation echocardiographic parameters level brain natriuretic peptide (BNP).We included 76 different cardiac symptoms hospitalized at Clinic for disease rheumatism. Control group (n = 26) was consisted without signs HF, normal left ventricle ejection fraction (LVEF) BNP level. Patients diagnosis HF 50) were subdivided into 2 depending on fluid overload:...

10.5455/medarh.2013.67.241-244 article EN Medical Archives 2013-01-01

Introduction: By development of the medicine, control risk factors for acute myocardial infarction (AMI), became foundation cardiology.Aim: To investigate association age with presence in patients infarction.Methods: The study had a prospective, comparative and descriptive character, it was done on sample 80 (n=80; 55 male 25 female) Clinic Heart, Blood Vessel Rheumatic Diseases, Clinical Center University Sarajevo from January 2016 to August 2018.All were hospitalized under diagnosis...

10.5455/medarh.2019.73.23-27 article EN Medical Archives 2019-01-01

<p><strong>Objectives.</strong> The aim of this research was to detect the presence depressive symptoms among student population at a Faculty Medicine, as well determine correlation between socio-demographic characteristics and students’ lifestyle symptoms.</p><p><strong>Subjects Methods. </strong>Of 800 students enrolled asked participate, 412 responded survey. study included Students from all 6 years studies. degree measured by 21-item revised form...

10.5644/ama2006-124.227 article EN cc-by-nc Acta Medica Academica 2018-12-26

Atrial fibrillation represents the most common cardiac arrhythmia in clinical practice. By year 2030, 14-17 million AF patients are anticipated European Union. remains one of major causes stroke, heart failure, sudden death all over world.The objective our study is to determine and cerebrovascular events (myocardial infarction, death) their cumulative incidence during 11 years follow up period.This includes 2352 ambulant hospitalized with atrial (AF) who were enrolled period. All underwent...

10.5455/medarh.2017.71.316-319 article EN Medical Archives 2017-01-01

Introduction:The commonest mitral regurgitation etiologies are degenerative (60%), rheumatic post-inflammatory, 12%) and functional (25%).Due to the large number of patients with acute MI, incidence ischaemic MR is also high.Ischaemic a complex multifactorial disease that involves left ventricular geometry, annulus, valvular/subvalvular apparatus.Ischaemic an important consequence LV remodeling after myocardial infarction.Research Objectives: The objective this study determine role...

10.5455/aim.2016.24.172-177 article EN Acta Informatica Medica 2016-01-01

Brain natriuretic peptide (BNP) is released from ventricular myocites due to their stretching and volume overload.In heart failure there BNP release.Aim of this study was observe release in acute myocardial infarction (AMI).We measured  patients with AMI.Control group (n=) similar by age gender AMI group.We found statistically signifi cant elevation compared controls (.pg/ml vs . pg/ml, p< .).Patients severe systolic dysfunction had the highest levels, while preserved...

10.17305/bjbms.2012.2470 article EN Bosnian Journal of Basic Medical Sciences 2012-08-20

Abstract D-dimer and fibrinogen are nonspecific diagnostic biomarkers for venous thromboembolism (VTE). The aim of this article was to present the values in relation anatomical localization deep vein thrombosis (DVT). This an observational study, which included 1,142 patients hospitalized from 2010 2019 at Department Angiology, Clinical Center University Sarajevo. Data on gender, age, location were collected all patients. Fibrinogen available 983 500 patients, respectively. Thrombosis...

10.1055/s-0042-1759819 article EN International Journal of Angiology 2023-01-13

Aim: γ-glutamyl transferase (GGT) is an independent prognostic marker for cardiac death and reinfarction in patients with coronary artery disease, but its clinical significance during early postmyocardial infarction period unclear. Patients & methods: This short-term prospective study included 40 acute myocardial (AMI) whom we determined GGT activity, lipids, uric acid, homocysteine (Hcy), high sensitivity C-reactive protein (hsCRP) left ventricular (LV) function on admission day 5 following...

10.2217/fca.11.43 article EN Future Cardiology 2011-09-01

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Aim&amp;lt;/strong&amp;gt; &amp;lt;br /&amp;gt;To examine the prevalence of depression in patients after acute myocardial infarction (AMI), as well relationship between and quality life.&amp;lt;br /&amp;gt;&amp;lt;strong&amp;gt;Methods&amp;lt;/strong&amp;gt; /&amp;gt;The survey was conducted via sociodemographic questionnaire, Beck Depression Inventory (BDI), Short Form 36&amp;lt;br /&amp;gt;Health Survey questionnaire (SF-36). The result SF-36 is...

10.17392/1404-21 article EN cc-by-nc-nd Medicinski Glasnik 2022-02-01

Atherosclerotic cardiovascular diseases (ASCVD) are still the leading cause of morbidity and mortality in Bosnia Herzegovina. Elevated LDL-cholesterol is established as a strong marker risk. Some researchers believe that measuring triglyceride levels gives good assessment residual risk for ASCVD besides measurement LDL-cholesterol.The aim this study was to evaluate overall prevalence major factors ASCVD, lipid profile 10-year fatal using HeartSCORE scoring system. Further, we want...

10.3233/thc-220874 article EN Technology and Health Care 2023-04-21

Perindopril is a tissue-specific ACE inhibitor with 24 hours long blood pressure-lowering effect, which protects vessels and decreases the variability of pressure.The aim our study was to investigate effectiveness safety perindopril in newly diagnosed or previously treated but uncontrolled adult hypertensive patients.This prospective cohort included primary care patients essential hypertension. Primary outcomes were decreasing arterial pressure normal levels (<140/90 mmHg), reducing systolic...

10.5455/msm.2020.32.4-9 article EN Materia Socio Medica 2020-01-01

Cardiomyopathies are diseases of the heart muscle, and present a heterogeneous group myocardial with mechanical or electrical dysfunction, characterized by ventricular hypertrophy dilatation. They can be strictly related to muscle (primary), as part systemic disease (secondary), represent factor that leads reduced quality life, occurrence failure mortality. The primary ones those genetic conditioning, mixed include dilated restrictive cardiomyopathy, acquired caused myocarditis,...

10.5937/galmed2305023d article EN Galenika Medical Journal 2023-01-01

Diabetes mellitus type 2 (T2DM) significantly increase the risk of cardiovascular (CV) disease morbidity and mortality. This study aimed to evaluate potential some novel anthropometric indices adipocytokines CV among T2DM patients.

10.12865/chsj.48.04.01 article EN PubMed 2023-06-12

Heart failure (HF) still remains as one of the most common causes hospital admission with a high mortality rate.To investigate possible prognostic role brain natriuretic peptide (BNP), high-sensitivity (hs) cardiac troponin (cTn) I, cystatin C, and cancer antigen 125 (CA125) in prediction decompensation after an index hospitalization to their additive value.Two hundred twenty-two patients hospitalized acute HF were monitored followed for 18 months.BNP at discharge has highest sensitivity...

10.4103/jfmpc.jfmpc_1456_22 article EN cc-by-nc-sa Journal of Family Medicine and Primary Care 2023-06-01

&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Aim&amp;lt;/strong&amp;gt; &amp;lt;br /&amp;gt;To evaluate the relationship between cardiovascular remodelling and glomerular filtration rate (eGFR) in pre-dialysis chronic kidney disease (CKD) patients without diseases (CVD) renal transplant recipients (RTR). /&amp;gt;&amp;lt;strong&amp;gt;Methods&amp;lt;br /&amp;gt;&amp;lt;/strong&amp;gt; The cross-sectional study included 83 with eGFR&amp;amp;lt;60 mL/min/1.73m 2 (45 CKD 3 stage 38 4 stage). Thirty...

10.17392/1009-19 article EN cc-by-nc-nd Medicinski Glasnik 2019-05-10
Coming Soon ...